Share-based Payment Arrangements | (2) Share-based Payment Arrangements As of March 26, 2022, the Company has an employee equity incentive plan, the 2011 equity incentive plan (the “2011 EIP”). The Company also has a stock compensation plan for members of its Board of Directors, the Amended and Restated 2013 Directors Stock Compensation Plan (as amended and restated as of May 17, 2016, the “2013 DSCP”). 6,000,000 shares of the Company’s common stock were authorized for issuance under the 2011 EIP and 115,000 shares of the Company’s common stock were authorized for issuance under the 2013 DSCP. The 2011 EIP and 2013 DSCP are each referred to herein as a “Plan,” and, collectively, as the “Plans.” Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands): Thirteen Weeks Ended March 26, 2022 March 27, 2021 Total cost of the Plans during the period $ 1,995 $ 4,029 Amount of related income tax benefit recognized during the period (3,360 ) (1,341 ) Net cost of the Plans during the period $ (1,365 ) $ 2,688 Included in income tax benefits recognized in the thirteen-week periods ended March 26, 2022 and March 27, 2021 were excess tax benefits from stock-based awards of $2,869,000 and $343,000, respectively. As of March 26, 2022, there were 56,502 shares of the Company’s common stock reserved for issuance under the 2013 DSCP and 3,230,826 shares of the Company’s common stock reserved for issuance under the 2011 EIP. Restricted Stock Units The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans: Number of Weighted Average Grant Date Outstanding at December 25, 2021 209,399 $ 102.90 Granted 49,405 $ 139.78 Shares earned in excess of target (1) 91,497 $ 92.58 Vested shares, including shares earned in excess of target (174,366 ) $ 96.14 Forfeited (15,044 ) $ 103.31 Outstanding at March 26, 2022 160,891 $ 115.64 (1) Represents additional shares earned under each of the February 2, 2017; February 2, 2018 and February 1, 2019 RSU awards as fiscal year 2021 financial results exceeded target performance level. During the thirteen-week period ended March 26, 2022, the Company granted RSUs with a performance condition. Outstanding RSUs at both December 25, 2021 and March 26, 2022 include RSUs with a performance condition and RSUs with a market condition, as further described below and in the Company’s 2021 Annual Report on Form 10-K. RSUs with a performance condition granted on January 28, 2022 may vest on January 31 of 2025, 2026 and 2027 based on growth in operating income and pre-tax The Company recognized approximately $ 1,301,000 and $3,223,000 of share-based compensation expense related to RSU awards in the thirteen-week periods ended March 26, 2022 and March 27, 2021, respectively. As of March 26, 2022, there was a maximum of $27.3 million of total unrecognized compensation cost related to RSU awards granted under the Plans with an expected average remaining life of approximately 3.9 years. With respect to RSU awards with a performance condition, the amount of future compensation expense to be recognized will be determined based on future operating results. Non-vested The following table summarizes information regarding the Company’s outstanding shares of non-vested Number of Shares and Deferred Weighted Average Grant Date Fair Value Non-vested 56,436 $ 125.16 Granted 17,008 $ 152.44 Vested (21,500 ) $ 110.16 Forfeited (2,302 ) $ 108.59 Non-vested 49,642 $ 141.77 The fair value of each share of non-vested non-vested As of March 26, 2022, there was $5,555,000 of total unrecognized compensation cost related to non-vested non-vested Stock Options The following table summarizes information regarding the Company’s outstanding stock options under the Plans: Number of Weighted Average Weighted Average Aggregate Intrinsic Options outstanding at December 25, 2021 8,570 $ 55.42 Exercised (3,500 ) $ 54.01 Options outstanding at March 26, 2022 5,070 $ 56.40 0.8 $ 495 Options exercisable at March 26, 2022 5,070 $ 56.40 0.8 $ 495 The total intrinsic value of stock options exercised during the thirteen-week periods ended March 26, 2022 and March 27, 2021 was $369,000 and $521,000, respectively. As of March 26, 2022, there was no unrecognized compensation cost related to stock options granted under the Plans. |